C46H44BrF6N11O2 — CID 161434183
4-[6-anilino-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methylbenzamide;4-[6-bromo-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methylbenzamide (PubChem CID 161434183) has the molecular formula C46H44BrF6N11O2 and a molecular weight of 976.82 g/mol. Its IUPAC name is 4-[6-anilino-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methylbenzamide;4-[6-bromo-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methylbenzamide.
| Compound Name | 4-[6-anilino-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methylbenzamide;4-[6-bromo-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methylbenzamide |
|---|---|
| PubChem CID | 161434183 |
| Molecular Formula | C46H44BrF6N11O2 |
| Molecular Weight | 976.82 g/mol |
| Exact Mass | 975.28 |
| IUPAC Name | 4-[6-anilino-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methylbenzamide;4-[6-bromo-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methylbenzamide |
| SMILES | Cc1cc(-c2cnc3c(NCCC(F)(F)F)cc(Br)nn23)ccc1C(=O)NC1CC1.Cc1cc(-c2cnc3c(NCCC(F)(F)F)cc(Nc4ccccc4)nn23)ccc1C(=O)NC1CC1 |
| InChI | InChI=1S/C26H25F3N6O.C20H19BrF3N5O/c1-16-13-17(7-10-20(16)25(36)33-19-8-9-19)22-15-31-24-21(30-12-11-26(27,28)29)14-23(34-35(22)24)32-18-5-3-2-4-6-18;1-11-8-12(2-5-14(11)19(30)27-13-3-4-13)16-10-26-18-15(9-17(21)28-29(16)18)25-7-6-20(22,23)24/h2-7,10,13-15,19,30H,8-9,11-12H2,1H3,(H,32,34)(H,33,36);2,5,8-10,13,25H,3-4,6-7H2,1H3,(H,27,30) |
| InChIKey | VYKOLNQOPYPPOZ-UHFFFAOYSA-N |
| XLogP | 10.43 |
| TPSA | 154.67 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 66 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 976.82 |
| LogP ≤ 5 | 10.43 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 11 |
| Structural Alerts | {'alert_name': 'het_6_tetrazine(18)', 'substructure': 'N/A'} |
|---|